These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31295543)

  • 1. Dynamically enhancing plaque targeting via a positive feedback loop using multifunctional biomimetic nanoparticles for plaque regression.
    Jiang C; Qi Z; He W; Li Z; Tang Y; Wang Y; Huang Y; Zang H; Yang H; Liu J
    J Control Release; 2019 Aug; 308():71-85. PubMed ID: 31295543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques.
    Zhao Y; Gao H; He J; Jiang C; Lu J; Zhang W; Yang H; Liu J
    J Control Release; 2018 Aug; 283():241-260. PubMed ID: 29885417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
    Zhang M; He J; Jiang C; Zhang W; Yang Y; Wang Z; Liu J
    Int J Nanomedicine; 2017; 12():533-558. PubMed ID: 28144137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
    Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
    Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein.
    Rong T; Wei B; Ao M; Zhao H; Li Y; Zhang Y; Qin Y; Zhou J; Zhou F; Chen Y
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of Lovastatin-Loaded Spherical Reconstituted High Density Lipoprotein for Efficient and Safe Anti-Atherosclerotic Therapy.
    Jiang C; Qi Z; Tang Y; Jia H; Li Z; Zhang W; Liu J
    Mol Pharm; 2019 Jul; 16(7):3284-3291. PubMed ID: 31117743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.
    Duivenvoorden R; Tang J; Cormode DP; Mieszawska AJ; Izquierdo-Garcia D; Ozcan C; Otten MJ; Zaidi N; Lobatto ME; van Rijs SM; Priem B; Kuan EL; Martel C; Hewing B; Sager H; Nahrendorf M; Randolph GJ; Stroes ES; Fuster V; Fisher EA; Fayad ZA; Mulder WJ
    Nat Commun; 2014; 5():3065. PubMed ID: 24445279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
    Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
    Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hesperidin blocks varenicline-aggravated atherosclerotic plaque formation in apolipoprotein E knockout mice by downregulating net uptake of oxidized low-density lipoprotein in macrophages.
    Koga M; Kanaoka Y; Inada K; Omine S; Kataoka Y; Yamauchi A
    J Pharmacol Sci; 2020 Jun; 143(2):106-111. PubMed ID: 32173266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
    Xu S; Li L; Yan J; Ye F; Shao C; Sun Z; Bao Z; Dai Z; Zhu J; Jing L; Wang Z
    Biomed Pharmacother; 2018 Jan; 97():1020-1031. PubMed ID: 29136780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis.
    Wang Y; Gao H; Huang X; Chen Z; Kang P; Zhou Y; Qin D; Zhang W; Liu J
    Carbohydr Polym; 2022 Sep; 292():119632. PubMed ID: 35725197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
    Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
    Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
    Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
    J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway.
    Geng J; Yang C; Wang B; Zhang X; Hu T; Gu Y; Li J
    Biomed Pharmacother; 2018 Jan; 97():941-947. PubMed ID: 29136772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy.
    Zhu L; Zhong Y; Yan M; Ni S; Zhao X; Wu S; Wang G; Zhang K; Chi Q; Qin X; Li C; Huang X; Wu W
    ACS Appl Mater Interfaces; 2024 Jun; 16(25):32027-32044. PubMed ID: 38867426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.
    Tardy C; Goffinet M; Boubekeur N; Cholez G; Ackermann R; Sy G; Keyserling C; Lalwani N; Paolini JF; Dasseux JL; Barbaras R; Baron R
    PLoS One; 2015; 10(9):e0137584. PubMed ID: 26335690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.
    Zhang WL; Xiao Y; Liu JP; Wu ZM; Gu X; Xu YM; Lu H
    Int J Pharm; 2011 Oct; 419(1-2):314-21. PubMed ID: 21835236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF
    Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.
    Bujold K; Rhainds D; Jossart C; Febbraio M; Marleau S; Ong H
    Cardiovasc Res; 2009 Aug; 83(3):457-64. PubMed ID: 19377069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.